WHO ICTRP trial
PARC Healthcare Survey
NL-OMON56764 · Overview of Medical Research in the Netherlands (NL-OMON) · Not Recruiting
Key facts
| Trial ID | NL-OMON56764 |
|---|---|
| Public title | PARC Healthcare Survey |
| Scientific title | PARC Healthcare Survey - PARC Healthcare Survey |
| Primary sponsor | Radboud Universiteit Nijmegen |
| Registry | Overview of Medical Research in the Netherlands (NL-OMON) |
| Recruitment status | Not Recruiting |
| Study type | Observational invasive |
| Countries | Netherlands |
| Conditions | Risico op kanker en reproductietoxiciteit en aangeboren afwijkingen risk of cancer and reproductive and developmental toxicity |
| Registration date | May 27, 2024 |
| Target size | 72 |
| Secondary IDs | NL86107.091.24 |
| Registry page | onderzoekmetmensen.nl |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: